These results support the theory that TREM-1 is an inflammatory response amplifier and suggest that the administration of TREM-1-producing monocytes alone is sufficient to induce both motor dysfunction and dopaminergic neuron loss in PD model mice, as well as to trigger neuroinflammation. Here, TREM1 is linked to Parkinson disease.